Get a Sample Research Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-nail-psoriasis-treatment-market
Psoriasis affecting the nail matrix or nail bed causes nail psoriasis, also known as psoriatic nail dystrophy, which causes specific and non-specific clinical changes in the nail. Psoriatic nail disease is frequently connected with chronic severe cutaneous psoriasis and may be a risk factor for the development of psoriatic arthritis. Nail psoriasis can affect people of various ethnicities, ages, and genders. The appearance of your toenails and fingernails is affected by nail psoriasis. It's possible that they'll thicken, acquire pinprick holes, and alter colour or shape. They can also be tender and painful.
Key Growth Drivers:
- Increasing Awareness and Diagnosis
With increasing awareness of nail psoriasis and improved diagnostic techniques, there is a growing number of individuals seeking treatment for this condition.
- Increasing Incidence of Psoriatic Arthritis
Psoriatic arthritis is a common complication of psoriasis, and nail involvement is a common feature of psoriatic arthritis. As a result, there is a growing demand for effective treatments for nail psoriasis in individuals with psoriatic arthritis.
The report outlines the involvement of key players, including:
Sun Pharmaceutical Industries Ltd. (India), Merck Sharp & Dohme Corp. (U.S.), Dr. Reddy’s Laboratories Ltd. (India), Cipla Inc. (India), AstraZeneca (U.K.), Johnson & Johnson Private Limited (India), Sanofi (France), Novartis AG (Switzerland), Bayer AG (Germany), LEO Pharma A/S (Denmark), Pfizer Inc. (U.S.), GlaxoSmithKline plc (U.K.), Eli Lilly and Company (U.S.), Sumitomo Dainippon Pharma Co., Ltd. (Japan), Amgen Inc. (U.S.), Zydus Cadila (India), Abbott (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Aurobindo Pharma (India), Lupin (India), and AbbVie Inc. (U.S.)
Key Market Segmentation
Treatment (Corticosteroids, Retinoid, Phototherapy, Biologics, Systemic Medications, Others), Diagnosis (Physical Examination, Biopsy, Others), Dosage (Tablet, Injection, Ointment, Others), Route of Administration (Oral, Injectable, Topical, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)
Know More about This Premium Research Report @ https://www.databridgemarketresearch.com/reports/global-nail-psoriasis-treatment-market
Browse More Reports:
https://www.databridgemarketresearch.com/reports/global-molecular-biology-kits-and-reagent-market
https://www.databridgemarketresearch.com/reports/global-electrostatic-live-cell-encapsulation-market
https://www.databridgemarketresearch.com/reports/global-pernicious-anemia-testing-market
https://www.databridgemarketresearch.com/reports/global-chromatography-in-cannabis-testing-market
https://www.databridgemarketresearch.com/reports/global-dental-intraoral-radiology-equipment-market
About Data Bridge Market Research, Private Ltd
Data Bridge Market Research is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe.
Contact Us
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email – [email protected]
